Skip to main content
. 2016 Mar 2;7(3):391–402. doi: 10.1016/j.jare.2016.02.006

Table 2.

Evidence grading used by the European Society of Liver Disease [EASL 2015] [16].

Notes Grading
Evidence quality
High Further research is very unlikely to change our confidence in the estimate of effect A
Moderate Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate B
Low Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Any change of estimate is uncertain C



Recommendation
Strong Factors influencing the strength of the recommendation included the quality of the evidence, presumed patient-important outcomes, and cost 1
Weak Variability in preferences and values, or more uncertainty. Recommendation is made with less certainty, higher cost or resource consumption 2